Sort
30,917 grants matching “tumor microenvironment”
The Role of CK2 in Glioblastoma Development
$336,263Etty N. Benveniste · University Of Alabama At Birmingham · R01 · FY2020 · CA
The Role of CK2 in Glioblastoma Development
$336,263Etty N. Benveniste · University Of Alabama At Birmingham · R01 · FY2018 · CA
Targeted therapy for breast cancer with osteolytic bone damage
$336,263Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2017 · CA
Targeted therapy for breast cancer with osteolytic bone damage
$336,263Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2016 · CA
Dietary intervention of non-classical Wnt signaling
$336,263Rajeev S Samant · University Of Alabama At Birmingham · R01 · FY2020 · CA
Dietary intervention of non-classical Wnt signaling
$336,263Rajeev S Samant · University Of Alabama At Birmingham · R01 · FY2018 · CA
Dietary intervention of non-classical Wnt signaling
$336,263Rajeev S Samant · University Of Alabama At Birmingham · R01 · FY2017 · CA
Functional proton-electron double-resonance imaging: development and application
$336,262Alexandre Valentin Samouilov · Ohio State University · R01 · FY2015 · EB
IDO1 and Immunotolerance in Glioblastoma
$336,225Derek Alan Wainwright · Northwestern University At Chicago · R01 · FY2018 · NS
Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet Transplants
$336,194Cherie L Stabler · University Of Florida · R01 · FY2023 · DK
Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet Transplants
$336,194Cherie L Stabler · University Of Florida · R01 · FY2022 · DK
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy
$336,191David G Denardo · Washington University · P50 · FY2020 · CA
The role of the tumor biofilm in determining tissue tropism
$336,170Kandice Tanner · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Molecular causes and mechanistic underpinning of breast cancer racial disparity
$336,158Seema Singh · University Of South Alabama · R01 · FY2019 · CA
Gamma/Delta Treg Cells and Human Breast Cancer
$336,158Guangyong Peng · Saint Louis University · R01 · FY2019 · CA
Role of CITED2 in Breast Cancer Bone Metastasis
$336,150Scott L Kominsky · Johns Hopkins University · R01 · FY2012 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2017 · CA
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer
$336,150Atul Bedi · Johns Hopkins University · R01 · FY2018 · CA
Bifunctional Immunostimulatory Antibodies for Treatment of Breast Cancer
$336,150Atul Bedi · Johns Hopkins University · R01 · FY2014 · CA
Ovarian cancer gene therapy using HPV pseudovirion
$336,150T.-C. Wu · Johns Hopkins University · R01 · FY2014 · CA
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer
$336,150Young J. Kim · Johns Hopkins University · R01 · FY2015 · CA
A novel NKG2D-specific BiTE cancer immunotherapy
$336,150Charles L Sentman · Dartmouth College · R01 · FY2015 · CA
Role of Tc17 cells in tumor immunotherapy
$336,150Charles G Drake · Johns Hopkins University · R01 · FY2015 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2016 · CA
Annexin A2 as a mediator of pancreatic cancer metastases
$336,150Lei Zheng · Johns Hopkins University · R01 · FY2015 · CA